Literature DB >> 10190921

Oral prednisolone is an effective adjuvant therapy for acute otitis media with discharge through tympanostomy tubes.

A Ruohola1, T Heikkinen, J Jero, T Puhakka, T Juvén, M Närkiö-Mäkelä, H Saxén, O Ruuskanen.   

Abstract

OBJECTIVE: To determine the efficacy of a short course of oral prednisolone as an adjuvant therapy for acute otitis media draining through tympanostomy tubes. STUDY
DESIGN: In a randomized, double-blind, placebo-controlled study, children with acute discharge (<48 hours) through tympanostomy tubes received either prednisolone (2 mg/kg/d; n = 23) or placebo (n = 27) for 3 days. All children received amoxicillin/clavulanate (40/10 mg/kg/d) for 7 days. The children were examined daily at the study clinic until the drainage ceased.
RESULTS: The median duration of otorrhea in the prednisolone group was 1.0 days (25% to 75% range, 1.0 to 2.0 days), compared with 3.0 days (25% to 75% range, 2.0 to 4.0 days) in the children receiving placebo (P <.001). The duration of otorrhea was </=2 days in 21 (91%) children in the prednisolone group, compared with 8 (30%) children in the placebo group (P <.001).
CONCLUSIONS: Oral prednisolone appears to be modestly effective adjuvant therapy for acute otitis media with discharge through tympanostomy tubes in children. Further studies seem warranted to determine whether short-term use of steroids early during the course of acute otitis media would also reduce the duration of middle ear effusion in children with intact tympanic membranes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10190921     DOI: 10.1016/s0022-3476(99)70204-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

Review 1.  WITHDRAWN: Interventions for ear discharge associated with grommets (ventilation tubes).

Authors:  Louise Vaile; Tim Williamson; Angus Waddell; Gordon J Taylor
Journal:  Cochrane Database Syst Rev       Date:  2016-11-15

2.  Oral prednisolone for acute otitis media in children: a pilot, pragmatic, randomised, open-label, controlled study (OPAL study).

Authors:  Respati W Ranakusuma; Amanda R McCullough; Eka D Safitri; Yupitri Pitoyo; Widyaningsih Widyaningsih; Christopher B Del Mar; Elaine M Beller
Journal:  Pilot Feasibility Stud       Date:  2020-08-29

3.  Control of chronic otitis media and sensorineural hearing loss in C3H/HeJ mice: glucocorticoids vs mineralocorticoids.

Authors:  Carol J MacArthur; J Beth Kempton; Jacqueline DeGagne; Dennis R Trune
Journal:  Otolaryngol Head Neck Surg       Date:  2008-11       Impact factor: 3.497

Review 4.  Acute otitis media in children with tympanostomy tubes.

Authors:  Jason Schmelzle; Richard V Birtwhistle; Andre K W Tan
Journal:  Can Fam Physician       Date:  2008-08       Impact factor: 3.275

5.  Use of an oligonucleotide array for laboratory diagnosis of bacteria responsible for acute upper respiratory infections.

Authors:  Stina B Roth; Jari Jalava; Olli Ruuskanen; Aino Ruohola; Simo Nikkari
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 6.  Interventions for children with ear discharge occurring at least two weeks following grommet (ventilation tube) insertion.

Authors:  Roderick P Venekamp; Faisal Javed; Thijs Ma van Dongen; Angus Waddell; Anne Gm Schilder
Journal:  Cochrane Database Syst Rev       Date:  2016-11-17

7.  Oral prednisolone for acute otitis media in children: protocol of a pilot randomised, open-label, controlled study (OPAL study).

Authors:  Respati W Ranakusuma; Amanda R McCullough; Eka D Safitri; Yupitri Pitoyo; Christopher B Del Mar; Elaine M Beller
Journal:  Pilot Feasibility Stud       Date:  2018-09-10

8.  Viral-Bacterial Synergy in Otitis Media: Implications for Management.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

Review 9.  Systemic corticosteroids for acute otitis media in children.

Authors:  Respati W Ranakusuma; Yupitri Pitoyo; Eka D Safitri; Sarah Thorning; Elaine M Beller; Sudigdo Sastroasmoro; Chris B Del Mar
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.